Cetera Investment Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Sell |
91,663
-9,329
| -9% | -$227K | ﹤0.01% | 1760 |
|
|
2025
Q1 | $2.1M | Sell |
100,992
-3,187
| -3% | -$66.2K | ﹤0.01% | 1718 |
|
|
2024
Q4 | $2.45M | Sell |
104,179
-6,010
| -5% | -$142K | 0.01% | 1505 |
|
|
2024
Q3 | $2.82M | Sell |
110,189
-8,608
| -7% | -$220K | 0.01% | 1368 |
|
|
2024
Q2 | $2.79M | Sell |
118,797
-22,100
| -16% | -$519K | 0.01% | 1329 |
|
|
2024
Q1 | $4.05M | Buy |
140,897
+104,831
| +291% | +$3.01M | 0.01% | 1094 |
|
|
2023
Q4 | $1.18M | Sell |
36,066
-3,392
| -9% | -$111K | 0.01% | 1011 |
|
|
2023
Q3 | $1.1M | Sell |
39,458
-1,755
| -4% | -$48.9K | 0.01% | 1006 |
|
|
2023
Q2 | $1.4M | Buy |
41,213
+828
| +2% | +$28.2K | 0.01% | 929 |
|
|
2023
Q1 | $1.21M | Buy |
40,385
+1,474
| +4% | +$44.3K | 0.01% | 943 |
|
|
2022
Q4 | $1.1M | Buy |
38,911
+1,522
| +4% | +$43K | 0.01% | 956 |
|
|
2022
Q3 | $1.23M | Sell |
37,389
-6,354
| -15% | -$209K | 0.02% | 635 |
|
|
2022
Q2 | $1.38M | Sell |
43,743
-1,371
| -3% | -$43.2K | 0.02% | 663 |
|
|
2022
Q1 | $2.07M | Sell |
45,114
-4,149
| -8% | -$191K | 0.03% | 550 |
|
|
2021
Q4 | $3.02M | Sell |
49,263
-13,492
| -21% | -$826K | 0.04% | 420 |
|
|
2021
Q3 | $4.69M | Sell |
62,755
-1,914
| -3% | -$143K | 0.07% | 277 |
|
|
2021
Q2 | $5.98M | Sell |
64,669
-30,466
| -32% | -$2.82M | 0.1% | 230 |
|
|
2021
Q1 | $8.44M | Buy |
95,135
+17,067
| +22% | +$1.51M | 0.17% | 131 |
|
|
2020
Q4 | $7.28M | Buy |
78,068
+64,665
| +482% | +$6.03M | 0.14% | 157 |
|
|
2020
Q3 | $854K | Buy |
+13,403
| New | +$854K | 0.07% | 281 |
|